A detailed history of Tema Etfs LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Tema Etfs LLC holds 22,474 shares of BPMC stock, worth $2.08 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
22,474
Holding current value
$2.08 Million
% of portfolio
0.81%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$82.48 - $101.39 $1.85 Million - $2.28 Million
22,474 New
22,474 $1.96 Billion

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.52B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Tema Etfs LLC Portfolio

Follow Tema Etfs LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tema Etfs LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tema Etfs LLC with notifications on news.